Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: Involvement of hydrogen peroxide-dependent and -independent action

Free Radical Biology and Medicine

Volumn 42, Issue 5, 2007, Pages 675-685

  Saito, Yoshiro ^a   Nishio, Keiko ^a   Ogawa, Yoko ^a   Kinumi, Tomoya ^a   Yoshida, Yasukazu ^a   Masuo, Yoshinori ^a   Niki, Etsuo ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

6 Hydroxydopamine; Caspase; Catalase; Cytochrome c; Glutathione; Hydrogen peroxide; p Quinone; Peroxiredoxin

Indexed keywords

CASPASE 3; CATALASE; CYTOCHROME C; HYDROGEN PEROXIDE; OXIDOPAMINE; PEROXIREDOXIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; MOLECULAR MECHANICS; NEUROTOXICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ANIMALS; ANTIOXIDANTS; BENZOQUINONES; CATALASE; CELL DEATH; CELL SURVIVAL; CYTOCHROMES C; CYTOTOXINS; HYDROGEN PEROXIDE; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; OXIDOPAMINE; PC12 CELLS; PEROXIDASES; RATS; SIGNAL TRANSDUCTION;

EID: 33846828453     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.12.004     Document Type: Article

References (46)

1. Jenner P., and Olanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (1996) S161-S170
2. Lotharius J., and Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev., Neurosci. 3 (2002) 932-942
3. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 Suppl. 3 (2003) S26-S36 (discussion S36-28)
4. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., and Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65 (2001) 135-172
5. Breese G.R., Knapp D.J., Criswell H.E., Moy S.S., Papadeas S.T., and Blake B.L. The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Res. Rev. 48 (2005) 57-73
6. Masuo Y., Ishido M., Morita M., and Oka S. Effects of neonatal 6-hydroxydopamine lesion on the gene expression profile in young adult rats. Neurosci. Lett. 335 (2002) 124-128
7. Jordan J., Galindo M.F., Tornero D., Gonzalez-Garcia C., and Cena V. Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells. J. Neurochem. 89 (2004) 124-133
8. Taira T., Saito Y., Niki T., Iguchi-Ariga S.M., Takahashi K., and Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 5 (2004) 213-218
9. Choi W.S., Eom D.S., Han B.S., Kim W.K., Han B.H., Choi E.J., Oh T.H., Markelonis G.J., Cho J.W., and Oh Y.J. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J. Biol. Chem. 279 (2004) 20451-20460
10. Liang Q., Liou A.K., Ding Y., Cao G., Xiao X., Perez R.G., and Chen J. 6-Hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression. J. Neurosci. Res. 77 (2004) 747-761
11. Hanrott K., Gudmunsen L., O'Neill M.J., and Wonnacott S. 6-Hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J. Biol. Chem. 281 (2006) 5373-5382
12. Chen Z.H., Saito Y., Yoshida Y., Sekine A., Noguchi N., and Niki E. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J. Biol. Chem. 280 (2005) 41921-41927
13. Chen Z.H., Yoshida Y., Saito Y., Sekine A., Noguchi N., and Niki E. Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-delta(12,14)-prostaglandin J2 through up-regulation of cellular glutathione via different mechanisms. J. Biol. Chem. 281 (2006) 14440-14445
14. Ochu E.E., Rothwell N.J., and Waters C.M. Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells. J. Neurochem. 70 (1998) 2637-2640
15. Xu R., Liu J., Chen X., Xu F., Xie Q., Yu H., Guo Q., Zhou X., and Jin Y. Ribozyme-mediated inhibition of caspase-3 activity reduces apoptosis induced by 6-hydroxydopamine in PC12 cells. Brain Res. 899 (2001) 10-19
16. Eminel S., Klettner A., Roemer L., Herdegen T., and Waetzig V. JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine. J. Biol. Chem. 279 (2004) 55385-55392
17. Tanaka K., and Ogawa N. Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice. Neurosci. Res. 51 (2005) 9-13
18. Cohen G., and Heikkila R.E. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 249 (1974) 2447-2452
19. Izumi Y., Sawada H., Sakka N., Yamamoto N., Kume T., Katsuki H., Shimohama S., and Akaike A. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. J. Neurosci. Res. 79 (2005) 849-860
20. Gee P., and Davison A.J. Intermediates in the aerobic autoxidation of 6-hydroxydopamine: relative importance under different reaction conditions. Free Radic. Biol. Med. 6 (1989) 271-284
21. Wolf P.S. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol. 233 (1994) 182-189
22. Andreae W.A. A sensitive method for the estimation of hydrogen peroxide in biological materials. Nature 175 (1955) 859-860
23. Kinumi T., Kimata J., Taira T., Ariga H., and Niki E. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 317 (2004) 722-728
24. Saito Y., Sato N., Hirashima M., Takebe G., Nagasawa S., and Takahashi K. Domain structure of bi-functional selenoprotein P. Biochem. J. 381 (2004) 841-846
25. Saito Y., Nishio K., Ogawa Y., Kimata J., Kinumi T., Yoshida Y., Noguchi N., and Niki E. Turning point in apoptosis/necrosis induced by hydrogen peroxide. Free Radic. Res. 40 (2006) 619-630
26. Przedborski S., and Ischiropoulos H. Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease. Antioxid. Redox Signal. 7 (2005) 685-693
27. 2 gradients across biomembranes. FEBS Lett. 475 (2000) 121-126
28. Wagner E., Luche S., Penna L., Chevallet M., Van Dorsselaer A., Leize-Wagner E., and Rabilloud T. A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem. J. 366 (2002) 777-785
29. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 15 (2001) 2922-2933
30. Soto-Otero R., Mendez-Alvarez E., Hermida-Ameijeiras A., Munoz-Patino A.M., and Labandeira-Garcia J.L. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J. Neurochem. 74 (2000) 1605-1612
31. Blum D., Torch S., Nissou M.F., Benabid A.L., and Verna J.M. Extracellular toxicity of 6-hydroxydopamine on PC12 cells. Neurosci. Lett. 283 (2000) 193-196
32. Mazzio E.A., Reams R.R., and Soliman K.F. The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro. Brain Res. 1004 (2004) 29-44
33. Rhee S.G., Chae H.Z., and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38 (2005) 1543-1552
34. Chang T.S., Jeong W., Woo H.A., Lee S.M., Park S., and Rhee S.G. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J. Biol. Chem. 279 (2004) 50994-51001
35. O'Brien P.J. Molecular mechanisms of quinone cytotoxicity. Chem.-Biol. Interact. 80 (1991) 1-41
36. Liang Y.O., Plotsky P.M., and Adams R.N. Isolation and identificaton of an in vivo reaction product of 6-hydroxydopamine. J. Med. Chem. 20 (1977) 581-583
37. Bolton J.L., Trush M.A., Penning T.M., Dryhurst G., and Monks T.J. Role of quinones in toxicology. Chem. Res. Toxicol. 13 (2000) 135-160
38. Adrain C., and Martin S.J. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem. Sci. 26 (2001) 390-397
39. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
40. Green D.R. Apoptotic pathways: paper wraps stone blunts scissors. Cell 102 (2000) 1-4
41. Nakagawa T., and Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 150 (2000) 887-894
42. Ryu E.J., Harding H.P., Angelastro J.M., Vitolo O.V., Ron D., and Greene L.A. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J. Neurosci. 22 (2002) 10690-10698
43. Holtz W.A., and O'Malley K.L. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J. Biol. Chem. 278 (2003) 19367-19377
44. Imai Y., Soda M., Inoue H., Hattori N., Mizuno Y., and Takahashi R. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105 (2001) 891-902
45. 2+ depletion induces endothelial cell apoptosis independently of caspase-12. Cardiovasc. Res. 69 (2006) 908-915
46. Wang X., Thomas B., Sachdeva R., Arterburn L., Frye L., Hatcher P.G., Cornwell D.G., and Ma J. Mechanism of arylating quinone toxicity involving Michael adduct formation and induction of endoplasmic reticulum stress. Proc. Natl. Acad. Sci. USA 103 (2006) 3604-3609